Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

Rolando & Melissa Toyos, ISOPT 2018 – IPL therapy and PRP eye drops for dry eye disease

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Mar 14th 2018

Rolando and Melissa Toyos talk about their current research into intense pulse light (IPL) therapy for dry eye disease. IPL therapy is a light treatment applied to the skin to stimulate the meibomian glands to produce a better tear. The current study looks at the efficacy of IPL versus meibomian gland expression, and the results will be available in around 6 months. Another area of research is the platelet rich plasma (PRP) eye drops in the treatment of a number of conditions including oculoplastic procedures.

Keywords: ISOPT 2018, Meibomian glands, dry eye disease, IPL, intense pulse light therapy, clinical trial, oculoplastics. PRP, platelet rich plasma

For more information about ISOPT Clinical please visit: www.isoptclinical.com

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup